- COVID-19
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 - NEJM
30-3-2020; 10.1056/NEJMsr2005760
By: Vaduganathan et al.
Aim
Review evidence on RAAS inhibitors and SARS-CoV-2
Key
ACE2 (an enzyme in RAAS) is the functional receptor to SARS-CoV-2.
Preclinical studies raised concerns on the safety of